Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
919
currently held
Exits tracked
338
hand-checked
Sectors covered
1
across the portfolio
Countries covered
35
from every market
1,150 companies matching · Page 12 of 23
Immutrin
CIC Fund II
Sector
Biotech
InvestorCambridge Innovation Capital
Entry
2025
Hold
1yr
InCephalo
HTGF IV
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2023
Hold
3yr
Indapta Therapeutics
Leaps by Bayer
Sector
Biotech
InvestorLeaps by Bayer
Entry
2022
Hold
4yr
Insilico Medicine
Warburg Pincus Asia Real Estate Fund, L.P.
Sector
Biotech
InvestorWarburg Pincus
Entry
–
InSphero
ZEISS Ventures CVC
Sector
Biotech
InvestorZEISS Ventures
Entry
2023
Hold
3yr
Intercus GmbH
MFT Mittelstands-Fonds Thueringen (MFT)
Sector
Biotech
Investorbm-t Beteiligungsmanagement Thueringen
Entry
2018
Hold
8yr
Invitris
10x Founders Fund I
Sector
Biotech
Investor10x Founders
Entry
2023
Hold
3yr
Invizius
Old College Capital LP
Sector
Biotech
InvestorOld College Capital
Entry
2019
Hold
7yr
iOnctura
XGEN Venture Life Sciences Fund
Sector
Biotech
InvestorXGen Venture SGR
Entry
2024
Hold
2yr
iosBio
Shackleton Ventures (Evergreen)
Sector
Biotech
InvestorShackleton Ventures
Entry
2020
Hold
6yr
Isarna
S-Refit AG
Sector
Biotech
InvestorSobera Capital
Entry
2016
Hold
10yr
Isarna Therapeutics
MIG Fonds 5
Sector
Biotech
InvestorMIG Capital
Entry
2005
Hold
21yr
Isavy Biotech
Generations powered by EDHEC
Sector
Biotech
InvestorRing Capital
Entry
–
Iteria Biopharma, S.L.
SODIGA Galicia
Sector
Biotech
InvestorXesGalicia
Entry
2026
Hold
0yr
Jurata Thin Film
Columbus Life Sciences Fund IV
Sector
Biotech
InvestorColumbus Venture Partners
Entry
2022
Hold
4yr
Juvena Therapeutics
Mubadala Capital Other Investments
Sector
Biotech
InvestorMubadala Capital
Entry
–
Kamau Therapeutics
Neva II
Sector
Biotech
InvestorNeva SGR
Entry
2024
Hold
2yr
Kano Therapeutics
Vsquared Ventures II
Sector
Biotech
InvestorVsquared Ventures
Entry
2024
Hold
2yr
KCAS
Vitruvian Investment Partnership IV
Sector
Biotech
InvestorVitruvian Partners
Entry
2021
Hold
5yr
Khloris Biosciences
Leaps by Bayer
Sector
Biotech
InvestorLeaps by Bayer
Entry
2019
Hold
7yr
Kiji Therapeutics
AFB Fund II
Sector
Biotech
InvestorAdBio Partners
Entry
2023
Hold
3yr
Kither Biotech
Claris Biotech I
Sector
Biotech
InvestorClaris Ventures SGR
Entry
2022
Hold
4yr
KLISBio
Principia III - Health
Sector
Biotech
InvestorPrincipia SGR
Entry
2016
Hold
10yr
Kula Bio
AgFunder Fund IV
Sector
Biotech
InvestorAgFunder
Entry
–
Kupando GmbH
Fruehphasen- und Wachstumsfonds Brandenburg
Sector
Biotech
InvestorBrandenburg Kapital
Entry
2022
Hold
4yr
LabGenius
Backed Fund I
Sector
Biotech
InvestorBACKED VC
Entry
2017
Hold
9yr
Laigo Bio
Angelini Ventures
Sector
Biotech
InvestorAngelini Ventures
Entry
2025
Hold
1yr
Launch Therapeutics
Abingworth Clinical Co-Development Fund 2
Sector
Biotech
InvestorAbingworth
Entry
2022
Hold
4yr
Lepure Biotech
General Atlantic Portfolio
Sector
Biotech
InvestorGeneral Atlantic
Entry
–
Leukos Biotech
Inveready Biotech II
Sector
Biotech
InvestorInveready Asset Management
Entry
2016
Hold
10yr
Libera Bio, S.L.
SODIGA Galicia
Sector
Biotech
InvestorXesGalicia
Entry
2022
Hold
4yr
Libera Biotech
Scientifica S.p.A. (Balance Sheet)
Sector
Biotech
InvestorScientifica Venture Capital
Entry
2022
Hold
4yr
Longevity Biotech
EMV Capital Evergreen Fund
Sector
Biotech
InvestorEMV Capital
Entry
2014
Hold
12yr
Loop Dee Science
GOCA3
Sector
Biotech
InvestorGo Capital
Entry
2023
Hold
3yr
LoQus23 Therapeutics
Dementia Discovery Fund
Sector
Biotech
InvestorSV Health Managers
Entry
2019
Hold
7yr
LUCA Science
4BIO Ventures III
Japan
Sector
Biotech
Investor4Bio Partners
Entry
2022
Hold
4yr
Macomics
Old College Capital LP
Sector
Biotech
InvestorOld College Capital
Entry
2020
Hold
6yr
March Biosciences
4BIO Ventures III
Sector
Biotech
Investor4Bio Partners
Entry
2024
Hold
2yr
MatchBio
Oxford Science Enterprises Balance Sheet
Sector
Biotech
InvestorOxford Science Enterprises
Entry
2024
Hold
2yr
MEDEA Biopharma
Caesar Ventures Fund I
Sector
Biotech
InvestorCaesar Ventures Management
Entry
2024
Hold
2yr
Medinect Bioservices Ltd
QUBIS Ltd
Sector
Biotech
InvestorQubis
Entry
2022
Hold
4yr
Meiogenix
Sofinnova Industrial Biotech
Sector
Biotech
InvestorSofinnova Partners
Entry
2019
Hold
7yr
Mereo BioPharma
Rosetta Capital V
Sector
Biotech
InvestorRosetta Capital
Entry
2021
Hold
5yr
Mesenbio
DSW Ventures
Sector
Biotech
InvestorDSW Venture Capital
Entry
2024
Hold
2yr
Mestag Therapeutics
SV7 Impact Medicine Fund
Sector
Biotech
InvestorSV Health Managers
Entry
2021
Hold
5yr
Micthera
Indaco BIO
Sector
Biotech
InvestorIndaco Venture Partners SGR
Entry
2024
Hold
2yr
Mimetic Medicine
AgFunder Fund IV
Sector
Biotech
InvestorAgFunder
Entry
–
Mimetic Medicines
AgFunder Fund IV
Sector
Biotech
InvestorAgFunder
Entry
–
Minoryx
Inveready Biotech I
Sector
Biotech
InvestorInveready Asset Management
Entry
2013
Hold
13yr
Modern Meadow
Evonik Venture Capital
Sector
Biotech
InvestorEvonik Venture Capital
Entry
2019
Hold
7yr